NASDAQ: EQEquillium Inc Stock Ownership - Who owns Equillium?
Insider buying vs selling
Have Equillium Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Jason A. Keyes | Chief Financial Officer | 2025-01-23 | 10,000 | $0.65 | $6.50kSell |
| Jason A. Keyes | Chief Financial Officer | 2024-12-10 | 15,000 | $0.54 | $8.10kBuy |
| Jason A. Keyes | Chief Financial Officer | 2024-11-14 | 10,000 | $0.70 | $7.00kSell |
| Penny Tom | Principal Accounting Officer | 2024-10-28 | 2,835 | $1.25 | $3.54kSell |
| Christine Zedelmayer | Sr. Vice President and COO | 2024-10-28 | 15,000 | $1.25 | $18.75kSell |
| Penny Tom | Principal Accounting Officer | 2024-10-25 | 683 | $1.25 | $853.75Sell |
| Jason A. Keyes | Chief Financial Officer | 2024-09-26 | 10,000 | $0.81 | $8.10kSell |
| Penny Tom | Principal Accounting Officer | 2024-09-16 | 38,806 | $0.85 | $32.99kSell |
EQ insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when EQ insiders and whales buy or sell their stock.
EQ Shareholders
What type of owners hold Equillium Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Decheng Capital LLC | 7.47% | 4,447,308 | $8.49M | Institution |
| Bruce D. Steel | 6.24% | 3,711,995 | $7.09M | Insider |
| Daniel Bradbury | 6.24% | 3,711,995 | $7.09M | Insider |
| Decheng Capital Global Life Sciences Fund IV LP | 5.52% | 3,285,710 | $6.28M | Insider |
| Sa Biocon | 3.89% | 2,316,134 | $4.42M | Insider |
| Takeda Pharmaceutical Co Ltd | 3.07% | 1,824,977 | $3.49M | Institution |
| Stephen Connelly | 1.67% | 993,000 | $1.90M | Insider |
| Vanguard Group Inc | 1.38% | 824,091 | $1.57M | Institution |
| Cota Capital Management LLC | 0.94% | 562,278 | $1.07M | Institution |
| Renaissance Technologies LLC | 0.46% | 274,100 | $523.53k | Institution |
EQ vs Biotech Stocks
Equillium Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.